Company profile
MeOmics - Biotech, Investment Opportunity
MeOmics is an incredible new biotech investment opportunity. Our mission is to improve the diagnosis and treatment of mental health illnesses.
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Jun 2022 to 31 May 2024
**The Challenge:** Severe mental illnesses (SMI), such as schizophrenia, causes immense suffering to those who experience it. It presents a significant cost burden, both for individuals (those experiencing schizophrenia have a reduced life expectancy of 10-25 years) and society, through lost workdays and care costs. New medications are needed to improve t...
